Skip to main content
See every side of every news story
Published loading...Updated

Ceo Leaves Ailing Ghent Biotech Company Biotalys

Summary by De Tijd
08:47 After half of the staff at Biotalys had to leave earlier this year, it is now the turn of the CEO of the Ghent-based biotech company, Kevin Helash. He is leaving at the very moment that Biotalys...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

08:47 After half of the staff at Biotalys had to leave earlier this year, it is now the turn of the CEO of the Ghent-based biotech company, Kevin Helash. He is leaving at the very moment that Biotalys...

·Belgium
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

De Tijd broke the news in Belgium on Tuesday, March 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal